Patent ID: 8476233
Filing Date: 2013-07-02
Classification: A61K,A61P

Abstract:
1. A method for the treatment of an inflammatory bowel disorder in a person or animal, said method comprising administering an effective amount of: a) a composition formulated for rectal administration as an enema or suppository in a person or animal, said composition comprising from about 500 mg to about 5000 mg of 5-ASA (Acetyl Salicylic Acid), from about 1 mg to about 10 mg of budesonide, from about 10 mg to about 1000 mg of cromolyn sodium and from about 5 millimoles to about 50 millimoles of sodium butyrate; and b) a composition formulated for oral administration, said composition comprising from about 100 mg to about 1000 mg of R-dihydro-lipoic acid to a person or animal in need thereof; wherein said inflammatory bowel disorder is ulcerative colitis.